Literature DB >> 24854309

Efficacy of 17α-ethynylestradiol-3-sulfate for severe hemorrhage in minipigs in the absence of fluid resuscitation.

Matthew Miller, James Keith, Jonathan Berman, D Bruce Burlington, Charles Grudzinskas, William Hubbard, Carl Peck, Charles Scott, Irshad H Chaudry.   

Abstract

BACKGROUND: Of the potentially survivable US battlefield deaths from 2001 to 2011, 80% to 91% were caused by severe hemorrhage. We subjected minipigs to acute severe blood loss, administered a single dose of 17α-ethynylestradiol-3-sulfate (EE-3-SO4) without resuscitative fluids, and determined survival as well as cardiovascular, biochemical, and physiologic response parameters.
METHODS: Following controlled removal of 60% circulating blood volume over 1 hour, minipigs received EE-3-SO4 at 0, 1, 3, or 5-mg/mL saline per kilogram of body weight in Experiment 1 (n = 25) and 0-, 0.1-, 0.3-, or 1-mg/mL saline per kilogram in Experiment 2 (n = 23). Survival times and response parameters were recorded for the next 6 hours.
RESULTS: Median survival times of the minipigs receiving 1 mg/kg (257 minutes and 360 minutes) were 1.8 times and 5 times those of the control group (140 minutes and 65 minutes) in Experiments 1 and 2, respectively. For both experiments combined, the log-rank p value was 0.0002, and the number of animals alive at 6 hours was 6 (50%) of 12 in the 1-mg/kg groups versus 0 (0%) of 12 in the control groups. Early increases in glucose, lactate, potassium, and phosphate as well as decreases in bicarbonate and mean arterial pressure correlated with shorter survival times.
CONCLUSION: Administration of a single dose of 1-mg/kg EE-3-SO4 in 1-mL/kg of saline following severe hemorrhage increased survival in 60% acutely bled minipigs by 3.5-fold. Slightly elevated blood pressure values, more physiologic values of oxidative phosphorylation parameters, and lower elevations of possible tissue necrosis parameters correlated with longer survival time. These results support the further product development of EE-3-SO4 for the indication of severe hemorrhage when standard resuscitative fluids are not available.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24854309     DOI: 10.1097/TA.0000000000000237

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  5 in total

1.  Ursolic acid inhibits superoxide production in activated neutrophils and attenuates trauma-hemorrhage shock-induced organ injury in rats.

Authors:  Tsong-Long Hwang; Hsin-I Shen; Fu-Chao Liu; Hsin-I Tsai; Yang-Chang Wu; Fang-Rong Chang; Huang-Ping Yu
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

2.  Better therapy for combat injury.

Authors:  Yong-Ming Yao; Hui Zhang
Journal:  Mil Med Res       Date:  2019-07-25

3.  17α-Ethinyl estradiol-3-sulfate increases survival and hemodynamic functioning in a large animal model of combined traumatic brain injury and hemorrhagic shock: a randomized control trial.

Authors:  Andrew R Mayer; Andrew B Dodd; Julie G Rannou-Latella; David D Stephenson; Rebecca J Dodd; Josef M Ling; Carissa J Mehos; Cidney R Robertson-Benta; Sharvani Pabbathi Reddy; Rachel E Kinsler; Meghan S Vermillion; Andrew P Gigliotti; Veronik Sicard; Amy L Lloyd; Erik B Erhardt; Jessica M Gill; Chen Lai; Vivian A Guedes; Irshad H Chaudry
Journal:  Crit Care       Date:  2021-12-16       Impact factor: 9.097

4.  Survival Rates and Biomarkers in a Large Animal Model of Traumatic Brain Injury Combined With Two Different Levels of Blood Loss.

Authors:  Andrew R Mayer; Andrew B Dodd; Josef M Ling; David D Stephenson; Julie G Rannou-Latella; Meghan S Vermillion; Carissa J Mehos; Victoria E Johnson; Andrew P Gigliotti; Rebecca J Dodd; Irshad H Chaudry; Timothy B Meier; Douglas H Smith; Denis E Bragin; Chen Lai; Chelsea L Wagner; Vivian A Guedes; Jessica M Gill; Rachel Kinsler
Journal:  Shock       Date:  2021-04-01       Impact factor: 3.533

Review 5.  Gender differences in trauma, shock and sepsis.

Authors:  Florian Bösch; Martin K Angele; Irshad H Chaudry
Journal:  Mil Med Res       Date:  2018-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.